In March 2024, the sale of 100% of the shares of Szőllős Investment Kft. to Vistin Pharma ASA was successfully closed.
Szőllős Investment Kft. was founded in 1996 and is a holding company active in the pharmaceutical industry.
Vistin Pharma ASA is a Norwegian based, listed holding company operating through its subsidiary Vistin Pharma AS, a pharmaceutical manufacturing company. The Company is a leading manufacturer and supplier of active pharmaceutical ingredients used in diabetes medicines.
The acquisition of Szőllős Investment Kft. is the first step for Vistin Pharma to become one of Europe’s leading multi-product API development and manufacturing organisations by increasing its product portfolio in line with its long-term strategy.
Concorde MB Partners was transaction advisor of seller.
